Jamjoom Pharmaceuticals Factory Co.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SA15QGU1UNH6
SAR
137.50
-3.3 (-2.34%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
396.22
457.53
259.70
327.58
345.74
385.46
207.86
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
396.22
457.53
259.70
327.58
345.74
385.46
207.86
Raw Material Cost
145.43
164.68
101.19
133.17
127.55
136.06
89.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.30
0.13
0.09
0.22
0.18
0.17
0.14
Selling and Distribution Expenses
108.43
126.50
95.05
89.56
106.50
113.97
73.03
Other Expenses
0.87
0.93
0.92
0.90
0.72
0.80
0.72
Total Expenditure (Excl Depreciation)
262.83
300.57
205.52
231.90
241.48
258.15
169.41
Operating Profit (PBDIT) excl Other Income
133.4
157
54.2
95.7
104.3
127.30000000000001
38.4
Other Income
3.39
3.04
-1.15
0.95
4.18
-15.40
-0.25
Operating Profit (PBDIT)
147.38
170.24
63.24
106.48
118.21
118.76
45.40
Interest
0.30
0.13
0.09
0.22
0.18
0.17
0.14
Exceptional Items
0.00
-0.03
-2.20
-2.22
-0.07
-0.04
3.73
Gross Profit (PBDT)
250.80
292.85
158.51
194.41
218.18
249.40
118.86
Depreciation
10.59
10.24
10.21
9.85
9.78
7.57
7.21
Profit Before Tax
136.49
159.84
50.74
94.19
108.18
110.97
41.78
Tax
7.01
6.77
6.86
6.27
3.24
9.76
2.62
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
132.02
157.03
51.61
94.99
106.95
102.97
44.48
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
132.02
157.03
51.61
94.99
106.95
102.97
44.48
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
132.02
157.03
51.61
94.99
106.95
102.97
44.48
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
1,681.79
1,546.52
1,490.61
1,444.63
1,463.22
1,461.50
1,404.33
Earnings per share (EPS)
1.89
2.24
0.74
1.36
1.53
1.47
0.64
Diluted Earnings per share
1.89
2.24
0.74
1.36
1.53
1.47
0.64
Operating Profit Margin (Excl OI)
33.67%
34.31%
20.86%
29.21%
30.16%
32.84%
18.49%
Gross Profit Margin
37.12%
37.17%
23.47%
31.76%
34.12%
30.75%
23.57%
PAT Margin
33.32%
34.32%
19.87%
29.0%
30.93%
26.71%
21.4%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is 14.61% vs 15.85% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is 23.36% vs 23.99% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is 26.32% vs 15.15% in Jun 2024

stock-summary

Interest

YoY Growth in quarter ended Jun 2025 is 50.00% vs 100.00% in Jun 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024

Compare Quarterly Results Of Jamjoom Pharmaceuticals Factory Co. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(SAR)
Change(%)
Net Sales
396.22
0
396.22
Other Operating Income
0.00
0.00
0.00
Total Operating income
396.22
0
396.22
Raw Material Cost
145.43
0
145.43
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.30
0
0.30
Selling and Distribution Expenses
108.43
0
108.43
Other Expenses
0.87
0.00
0.87
Total Expenditure (Excl Depreciation)
262.83
0
262.83
Operating Profit (PBDIT) excl Other Income
133.39
0.00
133.39
Other Income
3.39
0
3.39
Operating Profit (PBDIT)
147.38
0
147.38
Interest
0.30
0
0.30
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
250.80
0
250.80
Depreciation
10.59
0
10.59
Profit Before Tax
136.49
0
136.49
Tax
7.01
0
7.01
Provisions and contingencies
0
0
0.00
Profit After Tax
132.02
0
132.02
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
132.02
0
132.02
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
132.02
0
132.02
Equity Capital
0
0
0.00
Face Value
10.00
0
0.00
Reserves
1,681.79
0
1,681.79
Earnings per share (EPS)
1.89
0
1.89
Diluted Earnings per share
1.89
0
1.89
Operating Profit Margin (Excl OI)
33.67%
0%
0.00
33.67%
Gross Profit Margin
37.12%
0%
0.00
37.12%
PAT Margin
33.32%
0%
0.00
33.32%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 39.62 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -13.40% vs 76.16% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 14.61% vs 15.85% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 13.20 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -15.92% vs 204.26% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 23.36% vs 23.99% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 14.40 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -13.88% vs 159.63% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 26.32% vs 15.15% in Jun 2024

Quarterly - Interest
Interest 0.03 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 200.00% vs 0.00% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 50.00% vs 100.00% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 33.67%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024